MannKind Corp (MNKD) stock
MNKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30120% above fair value
$3.96−0.17 (-4.24%)
Close on Nov 16, 2026Market cap $1.27BP/E –Yield –
MannKind total assets
Total assets on the balance sheet at the end of each period.
MannKind's total assets was $732.30M at Jun 30, 2026. For fiscal 2025 it was $792.18M, up 101.1% from the year before. Over ten years it grew 20.1% a year on average. The highest annual figure on record is $792.18M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $792.18M | +101.1% |
| FY2024 | Dec 31, 2024 | $393.84M | -17.1% |
| FY2023 | Dec 31, 2023 | $475.20M | +60.9% |
| FY2022 | Dec 31, 2022 | $295.28M | -8.1% |
| FY2021 | Dec 31, 2021 | $321.16M | +195.7% |
| FY2020 | Dec 31, 2020 | $108.61M | +15.9% |
| FY2019 | Dec 31, 2019 | $93.73M | -13.0% |
| FY2018 | Dec 31, 2018 | $107.71M | +27.3% |
| FY2017 | Dec 31, 2017 | $84.58M | -21.0% |
| FY2016 | Dec 31, 2016 | $107.06M | -15.3% |
| FY2015 | Dec 31, 2015 | $126.41M | -68.0% |
| FY2014 | Dec 31, 2014 | $394.44M | +52.5% |
| FY2013 | Dec 31, 2013 | $258.65M | +2.9% |
| FY2012 | Dec 31, 2012 | $251.31M | +25.9% |
| FY2011 | Dec 31, 2011 | $199.55M | -28.0% |
| FY2010 | Dec 31, 2010 | $277.26M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $732.30M | +77.9% |
| Q1 FY2026 | Mar 31, 2026 | $744.40M | +81.5% |
| Q4 FY2025 | Dec 31, 2025 | $792.18M | +101.1% |
| Q3 FY2025 | Sep 30, 2025 | $494.64M | +6.6% |
| Q2 FY2025 | Jun 30, 2025 | $411.70M | -7.2% |
| Q1 FY2025 | Mar 31, 2025 | $410.14M | -14.7% |
| Q4 FY2024 | Dec 31, 2024 | $393.84M | -17.1% |
| Q3 FY2024 | Sep 30, 2024 | $464.20M | +44.9% |
| Q2 FY2024 | Jun 30, 2024 | $443.84M | +41.6% |
| Q1 FY2024 | Mar 31, 2024 | $480.88M | +61.3% |
| Q4 FY2023 | Dec 31, 2023 | $475.20M | +60.9% |
| Q3 FY2023 | Sep 30, 2023 | $320.33M | +9.0% |
| Q2 FY2023 | Jun 30, 2023 | $313.42M | +9.7% |
| Q1 FY2023 | Mar 31, 2023 | $298.14M | -3.3% |
| Q4 FY2022 | Dec 31, 2022 | $295.28M | -8.1% |
| Q3 FY2022 | Sep 30, 2022 | $293.84M | +23.4% |
| Q2 FY2022 | Jun 30, 2022 | $285.80M | +13.1% |
| Q1 FY2022 | Mar 31, 2022 | $308.32M | -3.5% |
| Q4 FY2021 | Dec 31, 2021 | $321.16M | +195.7% |
| Q3 FY2021 | Sep 30, 2021 | $238.21M | +149.0% |
| Q2 FY2021 | Jun 30, 2021 | $252.79M | +146.0% |
| Q1 FY2021 | Mar 31, 2021 | $319.38M | +298.2% |
| Q4 FY2020 | Dec 31, 2020 | $108.61M | +15.9% |
| Q3 FY2020 | Sep 30, 2020 | $95.68M | +0.6% |
| Q2 FY2020 | Jun 30, 2020 | $102.78M | +25.7% |
| Q1 FY2020 | Mar 31, 2020 | $80.21M | -20.6% |
| Q4 FY2019 | Dec 31, 2019 | $93.73M | -13.0% |
| Q3 FY2019 | Sep 30, 2019 | $95.14M | +109.8% |
| Q2 FY2019 | Jun 30, 2019 | $81.80M | +31.6% |
| Q1 FY2019 | Mar 31, 2019 | $100.96M | +63.2% |
| Q4 FY2018 | Dec 31, 2018 | $107.71M | +27.3% |
| Q3 FY2018 | Sep 30, 2018 | $45.36M | -19.7% |
| Q2 FY2018 | Jun 30, 2018 | $62.16M | -21.7% |
| Q1 FY2018 | Mar 31, 2018 | $61.88M | -27.4% |
| Q4 FY2017 | Dec 31, 2017 | $84.58M | -21.0% |
| Q3 FY2017 | Sep 30, 2017 | $56.48M | -41.2% |
| Q2 FY2017 | Jun 30, 2017 | $79.37M | – |
| Q1 FY2017 | Mar 31, 2017 | $85.19M | – |
| Q4 FY2016 | Dec 31, 2016 | $107.06M | – |
| Q3 FY2016 | Sep 30, 2016 | $96.13M | – |
See a number that looks wrong?